HAMP and breast carcinoma: Starting from previous considerations, and specifically, from the evidence that hepcidin and ferritin increase in plasma of breast cancer patients but not in patients with benign conditions, we speculated to find alterations in the expression of factors reflecting dysfunctional iron metabolism in cancerous conditions.